PK MED specializes in the development of custom-designed, biodegradable micro-implants for intravenous drug delivery, enabling targeted local treatments. This technology addresses the need for effective, localized therapy while minimizing systemic side effects associated with traditional drug administration methods.
Funding
$1.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional intravenous drug delivery methods often result in systemic side effects due to the drug circulating throughout the entire body. This lack of targeted delivery can reduce the effectiveness of the treatment and increase the risk of adverse reactions in healthy tissues. Achieving localized therapeutic concentrations without exposing the entire system to the drug remains a significant challenge.
Solution
PK MED develops custom-designed, biodegradable micro-implants that enable targeted intravenous drug delivery directly to the affected area. These micro-implants are designed to release medication locally, maximizing therapeutic impact while minimizing systemic exposure and associated side effects. By delivering drugs precisely where they are needed, PK MED's technology aims to improve treatment outcomes and reduce patient burden compared to traditional methods. The biodegradable nature of the implants eliminates the need for surgical removal, further simplifying the treatment process.
Target Audience
PK MED's primary customers are medical professionals and healthcare providers seeking advanced drug delivery solutions for localized treatments.
Features
- Custom-designed micro-implants tailored to specific drug delivery requirements
- Biodegradable materials that dissolve naturally, eliminating the need for removal
- Targeted intravenous delivery for localized treatment
- Minimization of systemic side effects through precise drug placement